Earnings Feed
Start Free
Home/Filings/4/0001415889-22-003744
4//SEC Filing

Greenfield Andrew J 4

Accession 0001415889-22-003744

CIK 0000815094other
View on SEC.govCompany Profile

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 5:10 PM ET

Size

18.9 KB

Accession

0001415889-22-003744

Insider Transaction Report

Form 4
Period: 2022-03-31
ABIOMED INCNASD
Greenfield Andrew J
VP Healthcare Solutions
Transactions
  • Award

    Common Stock, $.01 par value

    2022-03-31+25→ 43,245 total
Holdings

  • Stock Option (right to buy)

    Exercise: $134.51From: 2018-05-15Exp: 2027-05-15→ Common Stock (0 underlying)
    6,500

  • Stock Option (right to buy)

    Exercise: $283.88From: 2022-05-25Exp: 2031-05-25→ Common Stock (0 underlying)
    2,868

  • Common Stock, $.01 par value

    (indirect: By Trust)
    12,032

  • Stock Option (right to buy)

    Exercise: $266.39From: 2020-05-30Exp: 2029-05-30→ Common Stock (0 underlying)
    7,000

  • Stock Option (right to buy)

    Exercise: $99.62From: 2017-05-24Exp: 2026-05-24→ Common Stock (0 underlying)
    5,000

  • Stock Option (right to buy)

    Exercise: $381.97From: 2019-05-16Exp: 2028-05-16→ Common Stock (0 underlying)
    4,000

  • Stock Option (right to buy)

    Exercise: $223.90From: 2021-05-29Exp: 2030-05-29→ Common Stock (0 underlying)
    4,896
Footnotes (4)
  • [F1]These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c).
  • [F2]These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c).
  • [F3]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
  • [F4]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.

Documents

2 files

Issuer

ABIOMED INC

CIK 0000815094

→
Entity typeother

Related Parties

1
  • filerCIK 0001372715

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:10 PM ET
Size
18.9 KB
View on SEC.gov